Angelini Pharma
  • Angelini Pharma Worldwide
    • Austria
    • Bulgaria
    • Czech Republic
    • France
    • Germany
    • Greece
    • Hungary
    • Italy
    • Nordics
    • Poland
    • Portugal
    • Romania
    • Russia
    • Slovakia
    • Spain
    • Switzerland
    • Turkey
    • United Kingdom
    • United States
  • Angelini Pharma
  • Who we are

    • About us
    • Vision, purpose & values
    • Production Plants
    • Key Financials
    • People
    • What we do
    • Key facts and events
  • Core areas

    • Brain Health
    • Consumer Health
  • R&D

    • Science & Innovation
    • Clinical Trials
    • Research collaborations
    • Independent Research (IIT/RIS)
  • Partnering
  • Our Responsibility

    • Sustainability
    • Projects
    • Diversity & Inclusion
    • Ethics
    • Quality and EHS
    • Transparency
  • Media

    • News
    • Press releases
    • Press kit
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. News & publications
  3. News

News

News 1030

Mental Health

load more

See also

  1. Press releases

    Press releases
  2. Press kit

    Press kit
  3. Media center

    Media center
  • Top Employer Europe 2025
  • Privacy
  • Cookie Policy
  • Terms of use
  • Accessibility declaration
  • Webscraping
  • Transparency
  • Contact
  • Site map
  • Credits
  • Cookie settings
  • Twitter
  • Linkedin
  • Instagram

Angelini Pharma S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2025 © Angelini S.p.a. - All Rights Reserved

Part of Angelini Industries

Close menu